Evaluation of preoperative ProstaScint™ scans in the prediction of nodal disease
- 1 June 2002
- journal article
- clinical trial
- Published by Springer Nature in Prostate Cancer and Prostatic Diseases
- Vol. 5 (2) , 132-135
- https://doi.org/10.1038/sj.pcan.4500570
Abstract
Prostate Cancer and Prostatic Diseases, covering all aspects of prostatic diseases, in particular prostate cancer. The journal is of interest to surgeons, oncologists, clinicians, and researchers involved in disease of the prostate.Keywords
This publication has 9 references indexed in Scilit:
- Radioimmunoguided imaging of prostate cancer foci with histopathological correlationInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Indium-111-capromab pendetide scans: an important test relevant to clinical decision makingUrology, 2001
- Immunoscintigraphy with indium-111-capromab pendetide: evaluation before definitive therapy in patients with prostate cancerUrology, 1999
- Comparison of clinical staging algorithms and111Indium-capromab pendetide immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patientsCancer, 1999
- ProstaScint® scan may enhance identification of prostate cancer recurrences after prostatectomy, radiation, or hormone therapy: Analysis of 136 scans of 100 patientsThe Prostate, 1998
- Multicenter radioimmunoscintigraphic evaluation of patients with prostate carcinoma using indium-111 capromab pendetideCancer, 1998
- ( 111 ) INDIUM-CAPROMAB PENDETIDE IN THE EVALUATION OF PATIENTS WITH RESIDUAL OR RECURRENT PROSTATE CANCER AFTER RADICAL PROSTATECTOMYJournal of Urology, 1998
- Capromab PendetideDrugs & Aging, 1998
- Radioimmunoscintigraphy of Pelvic Lymph Nodes with111Indium-Labeled Monoclonal Antibody CYT-356Journal of Urology, 1994